Compare Pfizer with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs DISHMAN PHARMA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER DISHMAN PHARMA PFIZER/
DISHMAN PHARMA
 
P/E (TTM) x 42.4 25.1 168.8% View Chart
P/BV x 7.0 3.3 210.2% View Chart
Dividend Yield % 0.5 0.7 73.1%  

Financials

 PFIZER   DISHMAN PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-19
DISHMAN PHARMA
Mar-16
PFIZER/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs3,840374 1,025.6%   
Low Rs2,080129 1,613.7%   
Sales per share (Unadj.) Rs455.0197.8 230.0%  
Earnings per share (Unadj.) Rs93.821.2 442.2%  
Cash flow per share (Unadj.) Rs109.434.7 315.0%  
Dividends per share (Unadj.) Rs22.502.00 1,125.0%  
Dividend yield (eoy) %0.80.8 95.6%  
Book value per share (Unadj.) Rs658.2179.9 365.9%  
Shares outstanding (eoy) m45.7580.69 56.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.51.3 511.4%   
Avg P/E ratio x31.611.9 266.0%  
P/CF ratio (eoy) x27.17.2 373.4%  
Price / Book Value ratio x4.51.4 321.5%  
Dividend payout %24.09.4 254.4%   
Avg Mkt Cap Rs m135,42020,306 666.9%   
No. of employees `0002.60.8 317.4%   
Total wages/salary Rs m3,2385,355 60.5%   
Avg. sales/employee Rs Th7,911.419,252.7 41.1%   
Avg. wages/employee Rs Th1,230.96,459.5 19.1%   
Avg. net profit/employee Rs Th1,630.72,064.1 79.0%   
INCOME DATA
Net Sales Rs m20,81515,961 130.4%  
Other income Rs m1,674265 630.7%   
Total revenues Rs m22,48916,226 138.6%   
Gross profit Rs m5,7124,103 139.2%  
Depreciation Rs m7141,091 65.5%   
Interest Rs m73944 7.7%   
Profit before tax Rs m6,5992,334 282.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,309624 370.2%   
Profit after tax Rs m4,2911,711 250.7%  
Gross profit margin %27.425.7 106.7%  
Effective tax rate %35.026.7 130.9%   
Net profit margin %20.610.7 192.3%  
BALANCE SHEET DATA
Current assets Rs m27,16711,018 246.6%   
Current liabilities Rs m8,9179,517 93.7%   
Net working cap to sales %87.79.4 932.3%  
Current ratio x3.01.2 263.2%  
Inventory Days Days68110 61.4%  
Debtors Days Days3035 86.4%  
Net fixed assets Rs m8,86216,304 54.4%   
Share capital Rs m458161 283.5%   
"Free" reserves Rs m29,65612,907 229.8%   
Net worth Rs m30,11314,516 207.5%   
Long term debt Rs m254,189 0.6%   
Total assets Rs m39,40029,805 132.2%  
Interest coverage x91.53.5 2,636.8%   
Debt to equity ratio x00.3 0.3%  
Sales to assets ratio x0.50.5 98.7%   
Return on assets %11.18.9 124.3%  
Return on equity %14.211.8 120.9%  
Return on capital %22.117.5 126.3%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m4284,952 8.6%   
Fx outflow Rs m786697 112.9%   
Net fx Rs m-3584,255 -8.4%   
CASH FLOW
From Operations Rs m9782,786 35.1%  
From Investments Rs m351-1,529 -23.0%  
From Financial Activity Rs m-1,099-941 116.7%  
Net Cashflow Rs m231316 72.9%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 3.7 202.7%  
FIIs % 4.9 12.7 38.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 22.1 107.2%  
Shareholders   85,207 46,261 184.2%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   STRIDES PHARMA SCIENCE  ELDER PHARMA  SUVEN LIFE SCIENCES  ALEMBIC PHARMA  WOCKHARDT  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

4 Reasons Why Sensex Surged 750 Points Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Mar 1, 2021 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS